TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22093311

Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg, s.c., 12 hours before and after surgery, then once daily for 7 consecutive days)
Number of subjects: 1928

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1928

Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg, s.c.)
Number of subjects: 1928
Study: 20092769

Group type: EXPERIMENTAL
Intervention: Circumferential fusion
Number of subjects: 437

Group type: COMPARATOR
Intervention: Posterolateral fusion
Number of subjects: 437
Study: 16707508

Group type: EXPERIMENTAL
Intervention: Patient completed agenda form
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Education for general practitioners
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Both interventions (agenda form and education)
Number of subjects: 976

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 976
Study: 14636907

Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GFR >/=90 ml/min/1.73 m(2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hematocrit >/=36%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lowest hematocrit-GFR risk class (hematocrit >/=36%, GFR >/=90 ml/min/1.73 m(2))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Highest risk class (hematocrit <33%, GFR <60 ml/min/1.73 m(2))
Number of subjects: 0
Study: 10578020

Group type: EXPERIMENTAL
Intervention: OKG (20g OKG/d)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (Two Cal HN, 1.4 times BEE calories)
Number of subjects: 14
Study: 7812924

Group type: EXPERIMENTAL
Intervention: BCG prophylactic therapy (40 mg monthly for 12 times) - Group A
Number of subjects: 138

Group type: COMPARATOR
Intervention: Untreated control group - Group B
Number of subjects: 138
Study: 2013661

Group type: EXPERIMENTAL
Intervention: Fluff pulp and superabsorbent materials in various pad types
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Superabsorbent material
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Securing the pad with appropriate net pants
Number of subjects: 45
Study: 7174304

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study: 31540014

Group type: EXPERIMENTAL
Intervention: Regular gluten-free diet (R-GFD)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Low-FODMAP gluten-free diet (LF-GFD)
Number of subjects: 46
Study: 28877896

Group type: EXPERIMENTAL
Intervention: Potassium- and magnesium-enriched salt (K/Mg salt)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Potassium-enriched salt (K salt)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Regular salt (Na salt)
Number of subjects: 291
Study: 26735058

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy with a pulsed wave form, visible ray, wave length of 632.8 nm, 30 mW peak power, applied for 80 seconds (4J/cm2), 12 appointments (3 weekly in alternated days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 16
Study: 24210208

Group type: EXPERIMENTAL
Intervention: Parents recorded their child's micturition using a video camera.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Parents were told to have their child drink enough fluids and come with a full bladder.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group where parents were not given any follow-up visit direction.
Number of subjects: 30
Study: 21505146

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (nonobese subjects)
Number of subjects: 8
Study: 18465723

Group type: EXPERIMENTAL
Intervention: Preserved levobunolol
Number of subjects: 27

Group type: COMPARATOR
Intervention: Unpreserved levobunolol
Number of subjects: 27
Study: 16861077

Group type: EXPERIMENTAL
Intervention: Resilon/Epiphany
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: gutta‐percha/Roth (set for 3 weeks)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: gutta‐percha/Roth
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Resilon/Epiphany (single cone)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Resilon cones without primer/sealer (positive control)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: gutta‐percha/AH Plus
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: gutta‐percha/AH Plus (set for 8 hours)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Nail varnish sealing (negative control)
Number of subjects: 96
Study: 14553869

Group type: EXPERIMENTAL
Intervention: Minocycline‐rifampin-coated catheters
Number of subjects: 130

Group type: COMPARATOR
Intervention: Unimpregnated catheters
Number of subjects: 130
Study: 10910851

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil 20 microg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Epidural fentanyl 100 microg
Number of subjects: 46
Study: 8757204

Group type: EXPERIMENTAL
Intervention: Bradykinin 1 microgram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bradykinin 10 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: African American race
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 0
Study: 1333708

Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 20

Group type: COMPARATOR
Intervention: Teturam
Number of subjects: 20
Study: 6384377

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 545

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 545
Study: 29772945

Group type: EXPERIMENTAL
Intervention: Uterocervical angle (UCA) ≥97.5°
Number of subjects: 148

Group type: COMPARATOR
Intervention: Uterocervical angle (UCA) <97.5°
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Uterocervical angle (UCA)
Number of subjects: 148
Study: 31331137

Group type: EXPERIMENTAL
Intervention: Hetero‐Bevacizumab
Number of subjects: 111

Group type: COMPARATOR
Intervention: Reference Bevacizumab (RMP)
Number of subjects: 111
Study: 28169916

Group type: EXPERIMENTAL
Intervention: 2 mg E4
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 10 mg E4
Number of subjects: 49

Group type: COMPARATOR
Intervention: 2 mg E2V
Number of subjects: 49
Study: 26224299

Group type: EXPERIMENTAL
Intervention: Food, Activity, and Breastfeeding (FAB) intervention; Combination (FAB and Sleep)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Sleep intervention; Combination (FAB and Sleep)
Number of subjects: 802

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 802

Group type: COMPARATOR
Intervention: Sleep
Number of subjects: 802
Study: 24472479

Group type: EXPERIMENTAL
Intervention: RCT (standard chemotherapy)
Number of subjects: 680

Group type: COMPARATOR
Intervention: Off-trial (standard chemotherapy)
Number of subjects: 680
Study: 21114776

Group type: EXPERIMENTAL
Intervention: Calcium gluconate 1g + 15% magnesium sulphate 1g diluted in 100 mL of dextrose 5%
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 18080748

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with CMF (cyclophosphamide, methotrexate, fluorouracil; 600/40/600 mg/m(2))
Number of subjects: 423

Group type: COMPARATOR
Intervention: Postoperative chemotherapy (CMF or EC depending on node status)
Number of subjects: 423
Study: 16534210

Group type: EXPERIMENTAL
Intervention: Sweeping of membranes
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (no sweeping)
Number of subjects: 101
Study: 15015909

Group type: EXPERIMENTAL
Intervention: Music-based sessions
Number of subjects: 12

Group type: COMPARATOR
Intervention: Play-based sessions
Number of subjects: 12
Study: 11126468

Group type: EXPERIMENTAL
Intervention: Hispanic women
Number of subjects: 38

Group type: COMPARATOR
Intervention: Anglo women
Number of subjects: 38
Study: 9343270

Group type: EXPERIMENTAL
Intervention: Budesonide (0.4 mg/day)
Number of subjects: 28
Study: 8238327

Group type: EXPERIMENTAL
Intervention: 0.7 g AA.kg LBM‐1.day‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1.5 g AA.kg LBM‐1.day‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 2.5 g AA.kg LBM‐1.day‐1
Number of subjects: 6
Study: 2862898

Group type: EXPERIMENTAL
Intervention: Clobazam 20 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bromazepam 6 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Lorazepam 2 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 29755054

Group type: EXPERIMENTAL
Intervention: Training of Community Health Workers (CHWs)
Number of subjects: 15
Study: 26964730

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg/d
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Sildenafil (in db/db mice)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: COMPARATOR
Intervention: Vehicle (in db/db mice)
Number of subjects: 59
Study: 25299442

Group type: EXPERIMENTAL
Intervention: Cryotherapy followed by rehabilitation exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cryotherapy alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rehabilitation exercises alone
Number of subjects: 30
Study: 21742443

Group type: EXPERIMENTAL
Intervention: Chestnut tannins 10 g/kg diet (CT10)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Chestnut tannins 5 g/kg diet (CT5)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Basal diet (N)
Number of subjects: 4
Study: 21189196

Group type: EXPERIMENTAL
Intervention: Heel lifts of 6 mm
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Heel lifts of 9 mm
Number of subjects: 24

Group type: COMPARATOR
Intervention: Athletic shoes alone
Number of subjects: 24
Study: 18402729

Group type: EXPERIMENTAL
Intervention: Finasteride, a potent 5 alpha‐reductase inhibitor, measured in human plasma
Number of subjects: 0
Study: 16192529

Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Controlled-release naproxen sodium 1100 mg
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study: 12614467

Group type: EXPERIMENTAL
Intervention: IFN alpha‐2b 5 MU daily for 4 weeks followed by IFN (5 MU tiw) and ribavirin (1000‐1200 mg/day) for 48 weeks (Group A)
Number of subjects: 119

Group type: COMPARATOR
Intervention: IFN alpha‐2b 5 MU tiw for 4 weeks followed by IFN (5 MU tiw) and ribavirin (1000‐1200 mg/day) for 48 weeks (Group B)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Overall SVR in patients with genotype 1 or 4
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Overall SVR in patients with genotype 2 or 3
Number of subjects: 119
Study: 10539121

Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 164

Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 164
Study: 7977921

Group type: EXPERIMENTAL
Intervention: Nurse assessment visit and follow‐up interventions targeting risk factors for disability and falls (group 1, n = 635)
Number of subjects: 1559

Group type: EXPERIMENTAL
Intervention: General health promotion nurse visit (group 2, n = 317)
Number of subjects: 1559

Group type: COMPARATOR
Intervention: Usual care (group 3, n = 607)
Number of subjects: 1559
Study: 2508167

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cocaine infusion (40 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Instructed placebo (saline infusion with prior instruction)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Initial placebo session
Number of subjects: 8
Study: 184309

Group type: EXPERIMENTAL
Intervention: DBcAMP infusion at 10 mg/min for 20 min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DBcAMP infusion at 20 mg/min for 20 min
Number of subjects: 10
Study: 31526964

Group type: EXPERIMENTAL
Intervention: Whole-course nutrition management from the Nutrition Support Team
Number of subjects: 96

Group type: COMPARATOR
Intervention: General nutritional method (Control)
Number of subjects: 96
Study: 30500754

Group type: EXPERIMENTAL
Intervention: Multiple Linear Regression (MLR)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Random Forest Regression (RFR)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Blended MLR/RFR model
Number of subjects: 447

Group type: COMPARATOR
Intervention: Intervention status
Number of subjects: 447
Study: 28358852

Group type: EXPERIMENTAL
Intervention: Music training (MT group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No music training (NMT group)
Number of subjects: 60
Study: 25393158

Group type: EXPERIMENTAL
Intervention: Folic Acid for Vascular Outcome Reduction in Transplant trial medication
Number of subjects: 4110

Group type: EXPERIMENTAL
Intervention: Calcineurin inhibitor and statin
Number of subjects: 4110

Group type: EXPERIMENTAL
Intervention: Azathioprine and angiotensin-converting enzyme inhibitor
Number of subjects: 4110

Group type: EXPERIMENTAL
Intervention: Sulfonylurea
Number of subjects: 4110

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 4110
Study: 23579523

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 100
Study: 19463994

Group type: COMPARATOR
Intervention: Clomiphene
Number of subjects: 343

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 343

Group type: COMPARATOR
Intervention: Clomiphene + Metformin
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Lifestyle Modification
Number of subjects: 343
Study: 18308881

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) - 30 maximal inspirations daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cardiovascular Training (CV) - 4 week program with three running sessions per week
Number of subjects: 16
Study: 16669961

Group type: EXPERIMENTAL
Intervention: Oats
Number of subjects: 32

Group type: COMPARATOR
Intervention: Gluten challenge
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Oat-containing gluten-free diet
Number of subjects: 32
Study: 12814443

Group type: EXPERIMENTAL
Intervention: Haloperidol (10 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 10772526

Group type: EXPERIMENTAL
Intervention: Thymic transplantation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no thymic transplantation)
Number of subjects: 8
Study: 9193361

Group type: EXPERIMENTAL
Intervention: PIXY321 750 micrograms/m2/d divided into two subcutaneous doses
Number of subjects: 177

Group type: COMPARATOR
Intervention: GM‐CSF 250 micrograms/m2/d as a 2‐hour intravenous infusion
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: PIXY321
Number of subjects: 177

Group type: COMPARATOR
Intervention: GM‐CSF
Number of subjects: 177
Study: 1551960

Group type: EXPERIMENTAL
Intervention: Luteal phase support with a single dose of human chorionic gonadotrophin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Successful stimulation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Poor responders
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Early vascular maturation in the stroma
Number of subjects: 30
Study: 3925179

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 86

Group type: COMPARATOR
Intervention: No Heparin (Control)
Number of subjects: 86
Study: 30418100

Group type: EXPERIMENTAL
Intervention: Treadmill exercise training
Number of subjects: 184

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 184
Study: 30019627

Group type: EXPERIMENTAL
Intervention: Exenatide 5 µg subcutaneously twice daily
Number of subjects: 528

Group type: COMPARATOR
Intervention: Standard stroke unit care
Number of subjects: 528
Study: 27054828

Group type: EXPERIMENTAL
Intervention: Mindfulness in schools curriculum (8 lessons, once weekly)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Normal lessons (control group)
Number of subjects: 308
Study: 25175601

Group type: EXPERIMENTAL
Intervention: Incabotulinum toxin type A (iBTA) before conventional rehabilitation treatment (CT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline before conventional rehabilitation treatment (CT)
Number of subjects: 26
Study: 22923162

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) + daily dietary supplement containing arginine, Vinitrox, collagen, methyl‐sulfonyl‐methane, vitamin C, and bromelain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21462480

Group type: EXPERIMENTAL
Intervention: Weight reduction programme (dietary modifications of 1200-1400 kcal/day, physical activity modifications, behaviour therapy)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (30 healthy normal-weight children)
Number of subjects: 52
Study: 17638555

Group type: EXPERIMENTAL
Intervention: Laparoscopic nephrectomy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 45
Study: 15931678

Group type: EXPERIMENTAL
Intervention: 902 MHz mobile phone exposure at 0.025 W
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 902 MHz mobile phone exposure at 0.25 W
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham condition (0 W)
Number of subjects: 18
Study: 12402722

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.75% ropivacaine
Number of subjects: 40
Study: 9986921

Group type: EXPERIMENTAL
Intervention: CRH administration during SWS (protocol A)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: CRH administration during wakefulness (protocols B and C)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: GHRH pre-treatment
Number of subjects: 7

Group type: COMPARATOR
Intervention: Baseline condition (saline treatment only, protocol D)
Number of subjects: 7
Study: 7569030

Group type: EXPERIMENTAL
Intervention: Three fractions per day (multiple fractions per day, MFD) with misonidazole 1 g/m2/day
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Three fractions per day (multiple fractions per day, MFD) without misonidazole
Number of subjects: 523

Group type: COMPARATOR
Intervention: Conventional fractionation (70 Gy in 35 fractions, 7 weeks or 75 Gy in 44 fractions, 9 weeks)
Number of subjects: 523
Study: 1887473

Group type: EXPERIMENTAL
Intervention: Dapsone (100 mg) every 12 h for 6 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo tablets every 12 h for 6 weeks
Number of subjects: 120
Study: 6415182

Group type: EXPERIMENTAL
Intervention: Formalin‐inactivated vaccine (doses not specified)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Formalin‐inactivated vaccine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Unvaccinated controls
Number of subjects: 52
Study: 31776684

Group type: EXPERIMENTAL
Intervention: FLS program
Number of subjects: 195

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 195
Study: 29807933

Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3)
Number of subjects: 366
Study: 26731272

Group type: EXPERIMENTAL
Intervention: Sitting in a park
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Sitting in a cafe
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Walking in a shopping mall
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Walking along a busy street
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Attentional fatigue
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Being with a close friend
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Alone
Number of subjects: 496
Study: 25135724

Group type: EXPERIMENTAL
Intervention: Peg‐IFN alpha‐2b plus adefovir dipivoxil (10 mg daily) for 52 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Peg‐IFN alpha‐2b alone (1.5 μg/kg once weekly) for 52 weeks
Number of subjects: 61
Study: 22685578

Group type: EXPERIMENTAL
Intervention: Minocycline (400 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pregabalin (300 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Capsaicin (10 µg)
Number of subjects: 18
Study: 20414559

Group type: EXPERIMENTAL
Intervention: Therapeutic education and protective footwear program (n=30)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Intervention group (n=30)
Number of subjects: 53
Study: 17915972

Group type: EXPERIMENTAL
Intervention: Family intervention approach according to the McMaster Model and maintenance of the anti‐depressant drug at the same dosage
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dose increase and clinical management
Number of subjects: 20
Study: 16143228

Group type: COMPARATOR
Intervention: Calcium (500 mg elemental calcium, 400 IU Vitamin D3)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Raloxifene (60 mg/day)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Estrogen patches (3.9 mg estradiol) and progesterone (100 mg/day)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Calcium and Raloxifene (combined)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Raloxifene
Number of subjects: 136
Study: 12709272

Group type: EXPERIMENTAL
Intervention: Recombinant human albumin (rHA), n = 43
Number of subjects: 85

Group type: COMPARATOR
Intervention: Human serum albumin (HSA), n = 42
Number of subjects: 85
Study: 10189539

Group type: EXPERIMENTAL
Intervention: Human ultralente (UL) insulin
Number of subjects: 178

Group type: COMPARATOR
Intervention: Human NPH insulin
Number of subjects: 178

Group type: COMPARATOR
Intervention: Twice-daily NPH insulin
Number of subjects: 178
Study: 8850573

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (30 min of bench stepping at 15 steps min-1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Concentric exercise (30 min of uphill walking at 5 km h-1, 8% incline)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cycling at 80% VO2 max for 15 min after eccentric exercise
Number of subjects: 6
Study: 2407023

Group type: EXPERIMENTAL
Intervention: Norfloxacin (400 mg tablet twice daily)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (double strength tablet twice daily)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 93

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 93